TP53 and acute myeloid leukemia: By analyzing datasets from the Cancer Genome Atlas Research Network (TCGA) acute myeloid leukemia (AML) study, we discover that mutations and/or copy number variations of m<sup>6</sup>A regulatory genes are strongly associated with the presence of TP53 mutations in AML patients.